2 active not recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 2 |
| Phase 2 | 2 | Active not recruiting 2 |
Follow Vision Disorders: new trials by email Literature Review of Vision Disorders trials Research Report on Vision Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene QR-1123, Sham procedure - Autosomal Dominant Retinitis Pigmentosa, Eye Diseases | Phase 1 / Phase 2 | Active not recruiting | ProQR Therapeutics | 11 | 2019-10-07 | 2022-05-06 |
| Safety and Efficacy of rAAV.hCNGA3 Gene Therapy in Patients With CNGA3-linked Achromatopsia rAAV.hCNGA3 - Achromatopsia | Phase 1 / Phase 2 | Active not recruiting | STZ eyetrial | 13 | 2015-11-01 | 2024-04-18 |
Color Vision Defects (1) · Eye Diseases (1) · Eye Diseases, Hereditary (1) · Multiple Pterygium Syndrome, Autosomal Dominant (1) · Night Blindness, Congenital Stationary, Autosomal Dominant 1 (1) · Retinal Diseases (1) · Retinal Dystrophies (1) · Retinitis (1) · Retinitis Pigmentosa (1)
Nervous System Diseases (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Sensation Disorders (2) · Signs and Symptoms (2) · Cone Dystrophy (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Eye Diseases (1) · Eye Diseases, Hereditary (1) · Genetic Diseases, Inborn (1) · Retinal Degeneration (1)
ProQR Therapeutics (1) · STZ eyetrial (1)
Germany (1) · United States (1)
2014 (1)